Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Sales (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Return on Sales for 2 consecutive years, with 0.47% as the latest value for Q4 2025.

  • For Q4 2025, Return on Sales rose 178.0% year-over-year to 0.47%; the TTM value through Dec 2025 reached 0.7%, up 86.0%, while the annual FY2025 figure was 0.7%, 2.0% up from the prior year.
  • Return on Sales was 0.47% for Q4 2025 at Day One Biopharmaceuticals, up from 0.49% in the prior quarter.
  • The five-year high for Return on Sales was 0.38% in Q3 2024, with the low at 13.72% in Q2 2024.